NON-MYELOABLATIVE ALLOGENEIC STEM CELL TRANSPLANTATION (NST) IN PATIENTS WITH HIGH RISK LYMPHOMA: A SINGLE CENTRE EXPERIENCE

被引：0
|
作者：
Console, Giuseppe [1 ]
Messina, Giuseppe [1 ]
Martino, Massimo [1 ]
Morabito, Fortunato [1 ]
Irrera, Giuseppe [1 ]
Pucci, Giulia [1 ]
Penna, Giuseppa [1 ]
Cuzzola, Maria [1 ]
Iacopino, Olga [1 ]
Stelitano, Caterina [2 ]
Callea, Vincenzo [2 ]
Mamone, Domenico [3 ]
Kropp, Maria Grazia
Molica, Stefano [4 ]
Abbadessa, Antonio [5 ]
Iacopino, Pasquale [1 ]
机构：
[1] Azienda Osped Bianchi Melacrino Morelli, Ctr Trapianti Midollo Osseo, Reggio Di Calabria, Italy
[2] Azienda Osped Bianchi Melacrino Morelli, UO Ematol, Reggio Di Calabria, Italy
[3] Azienda Osped Papardo, UO Ematol, Messina, Italy
[4] Azienda Osped Pugliese Ciaccio, UO Oncol, Catanzaro, Italy
[5] Seconda Univ Napoli, Dipartimento Clin Internist & Sperimentale F Magr, Naples, Italy
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：79 / 79
页数：1
相关论文
共 50 条
  • [41] Non-myeloablative stem cell transplantation for the treatment of haematologic malignancies and metastatic solid tumours: a single-centre experience
    Cetin, M
    Altuntas, F
    Sari, I
    Eser, B
    Er, O
    Canoz, O
    Kaplan, B
    Ozkan, M
    Albayrak, E
    Bahar, S
    Ozkul, Y
    Patiroglu, T
    Unal, A
    BONE MARROW TRANSPLANTATION, 2004, 33 : S328 - S328
  • [42] Non-myeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
    Gerull, S
    Probst, S
    Ho, AD
    Goldschmidt, H
    Goerner, M
    Schaefer, H
    BLOOD, 2003, 102 (11) : 475B - 475B
  • [43] Impact of rituximab on immunomodulation and survival after non-myeloablative allogeneic stem cell transplantation (NST) for chronic lymphocytic leukemia (CLL).
    Khouri, IF
    Lee, MS
    Saliba, RM
    Korbling, M
    McMannis, JD
    Keating, MJ
    Champlin, RE
    BLOOD, 2003, 102 (11) : 727A - 727A
  • [44] Different immune reconstitution in patients with lymphoproliferative diseases after non-myeloablative and myeloablative allogeneic stem cell transplantation
    Dattola, A
    Condemi, A
    Cuzzola, M
    Iacopino, O
    Pontari, A
    Callea, I
    Martino, M
    Pucci, G
    Messina, G
    Irrera, G
    Console, G
    Marcuccio, D
    Morabito, F
    Iacopino, P
    BONE MARROW TRANSPLANTATION, 2005, 35 : S358 - S358
  • [45] Upfront tandem autologous non-myeloablative allogeneic stem cell transplant in high-risk multiple myeloma: a long-term single-centre experience
    Nguyen, Phillip C.
    Muirhead, Jenny
    Tan, Joanne
    Kalff, Anna
    Bergin, Krystal
    Walker, Patricia
    Spencer, Andrew
    INTERNAL MEDICINE JOURNAL, 2022, 52 (07) : 1263 - 1267
  • [46] Non-myeloablative allogeneic stem cell transplantation for the treatment of patients with chronic myeloid leukemia.
    Slavin, S
    Nagler, A
    Shapira, M
    Aker, M
    Or, R
    BLOOD, 2000, 96 (11) : 203A - 203A
  • [47] Results of an allogeneic non-myeloablative stem cell transplantation program in patients with chronic myelogenous leukemia
    Ruiz-Argüelles, GJ
    Gómez-Almaguer, D
    López-Martinez, B
    Cantú-Rodriguez, OG
    Jaime-Pérez, JC
    González-Llano, O
    HAEMATOLOGICA, 2002, 87 (08) : 894 - 896
  • [48] Non-myeloablative allogeneic hematopoietic stem cell transplantation in patients with acute myelogenous leukemia.
    Shapira, Michael Y.
    Panagiotis, Tsirigotis D.
    Or, Reuven
    Resnick, Igor B.
    Gesundheit, Benjamin
    Slavin, Shimon
    BLOOD, 2006, 108 (11) : 863A - 863A
  • [49] Non-Myeloablative Allogeneic Hematopoietic Stem Cell Transplantation in Hodgkin's Disease
    Hovgaard, Doris
    Sengelov, Henrik
    Vindelov, Lars
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (02) : S197 - S197
  • [50] A comparison of non-myeloablative versus reduced conditioning for allogeneic stem cell transplantation
    Ringdén, O
    Le Blanc, K
    Uzunel, M
    Mattsson, J
    Barkholt, L
    Remberger, M
    BONE MARROW TRANSPLANTATION, 2004, 33 : S38 - S38
12345